FIBROGEN INC 4
4 · FIBROGEN INC · Filed Nov 19, 2014
Insider Transaction Report
Form 4
FIBROGEN INCFGEN
Astellas Pharma Inc.
10% Owner
Transactions
- Conversion
Series F Convertible Preferred Stock
2014-11-19−1,208,800→ 0 total→ Common Stock (483,520 underlying) - Conversion
Series G Convertible Preferred Stock
2014-11-19−6,666,667→ 0 total→ Common Stock (2,666,666 underlying) - Conversion
Common Stock
2014-11-19+4,968,367→ 4,968,367 total - Conversion
Series D Convertible Preferred Stock
2014-11-19−4,545,454→ 0 total→ Common Stock (1,818,181 underlying)
Footnotes (1)
- [F1]Each share of the issuer's Series D Preferred Stock, Series F Preferred Stock and Series G Preferred Stock automatically converted into 0.4 of a share of common stock immediately prior to the closing of the issuer's initial public offering, and has no expiration date.